Impact of non‐selective beta blockers on further decompensation and death in decompensated cirrhosis: Benefit and risk stratification by MELD score

Documenti analoghi

• Editorial: Non‐selective beta‐blockers: A lifesaving shield for critically ill patients with acute decompensation of cirrhosis?
  di: Ling Yang, et al.
  Pubblicazione: (2024)
• Terlipressin therapy is associated with increased risk of colonisation with multidrug‐resistant bacteria in patients with decompensated cirrhosis
  di: Marcus M. Mücke, et al.
  Pubblicazione: (2024)
• Letter: Association of polymorphic variant of SerpinB3 and faster cirrhosis decompensation in patients with cirrhosis—More evidence needed
  di: Haibo Jing, et al.
  Pubblicazione: (2024)
• Letter: Association of polymorphic variant of SerpinB3 and faster cirrhosis decompensation in patients with cirrhosis—More evidence needed. Authors' reply
  di: Andrea Martini, et al.
  Pubblicazione: (2024)
• Letter: Fibrates may be safe and effective in patients with primary biliary cholangitis and decompensated cirrhosis—Authors' reply
  di: Lukas Burghart, et al.
  Pubblicazione: (2024)